The Centers for Disease Control and Prevention has issued a health advisory on the supply disruption of peritoneal dialysis and intravenous solutions due to the Baxter plant closure in North Carolina following Hurricane Helene. The advisory summarizes recommendations from the Food and Drug Administration; the Administration for Strategic Preparedness and Response Technical Resources, Assistance Center, and Information Exchange; the American Society of Health-System Pharmacists; the American Society of Nephrology; and the American Society of Pediatric Nephrology, among others, about addressing supply disruptions to PD and IV solutions.  

Baxter Oct. 9 announced it was increasing the current U.S. allocation levels of its highest-demand IV fluids for direct customers from 40% to 60%, and for distributors from 10% to 60%. For the latest on the IV solutions situation, including additional resources that hospitals and health systems can use for conservation efforts, visit AHA's webpage.

Related News Articles

Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Headline
The White House Aug. 13 released an executive order directing the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness…
Headline
The Food and Drug Administration Aug. 8 announced an end to the national shortage of sodium chloride 0.9% IV solutions products. The agency said it continues…
Headline
The Centers for Medicare & Medicaid Services July 10 announced it will provide resources and flexibilities to health care providers and residents who…
Headline
The Centers for Disease Control and Prevention March 4 announced it sent agency experts to Texas to assist local officials in responding to the state’s measles…
Headline
A school-aged child in Texas is the first reported individual to die from measles amid an outbreak in the South Plains and Panhandle regions of the state, the…